| Secondary |
| Product Used For Unknown Indication |
25.4% |
| Insomnia |
9.2% |
| Asthma |
5.8% |
| Constipation |
4.6% |
| Musculoskeletal Pain |
4.6% |
| Neck Pain |
4.6% |
| Pneumonia |
4.6% |
| Depression |
4.2% |
| Smoking Cessation Therapy |
4.2% |
| Weight Control |
4.2% |
| Schizophrenia |
3.8% |
| Breast Cancer |
3.5% |
| Gastritis |
3.1% |
| Periarthritis |
3.1% |
| Post Herpetic Neuralgia |
3.1% |
| Oedema |
2.7% |
| Anxiety |
2.3% |
| Cardiovascular Disorder |
2.3% |
| Proctalgia |
2.3% |
| Spinal Ligament Ossification |
2.3% |
|
| Interstitial Lung Disease |
14.7% |
| Weight Decreased |
8.8% |
| Vomiting |
7.4% |
| Pulmonary Alveolar Haemorrhage |
5.9% |
| Stevens-johnson Syndrome |
5.9% |
| Urine Colour Abnormal |
5.9% |
| Urticaria |
5.9% |
| Liver Disorder |
4.4% |
| Mixed Liver Injury |
4.4% |
| Neutrophil Count Decreased |
4.4% |
| Toxic Epidermal Necrolysis |
4.4% |
| Ventricular Tachycardia |
4.4% |
| Anaphylactic Shock |
2.9% |
| Anxiety |
2.9% |
| Chromaturia |
2.9% |
| Convulsion |
2.9% |
| Drug Eruption |
2.9% |
| Eosinophilic Pneumonia |
2.9% |
| Fatigue |
2.9% |
| Grand Mal Convulsion |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
12.1% |
| Drug Use For Unknown Indication |
8.7% |
| Hypertension |
8.0% |
| Prophylaxis |
6.9% |
| Depression |
6.4% |
| Analgesic Therapy |
6.0% |
| Constipation |
6.0% |
| Smoking Cessation Therapy |
5.0% |
| Pain |
4.3% |
| Diabetes Mellitus |
4.3% |
| Contraception |
4.2% |
| Colorectal Cancer |
4.0% |
| Hepatocellular Carcinoma |
3.9% |
| Rheumatoid Arthritis |
3.8% |
| Hepatic Neoplasm Malignant |
3.6% |
| Asthma |
2.7% |
| Osteoporosis |
2.6% |
| Bipolar Disorder |
2.6% |
| Premenstrual Syndrome |
2.6% |
| Insomnia |
2.5% |
|
| Weight Decreased |
11.5% |
| Weight Increased |
10.6% |
| Nausea |
6.0% |
| Vomiting |
6.0% |
| Pain |
5.5% |
| Pain In Extremity |
5.1% |
| Pulmonary Embolism |
5.1% |
| Urinary Incontinence |
5.1% |
| Hepatic Function Abnormal |
4.6% |
| Dyspnoea |
4.1% |
| Interstitial Lung Disease |
4.1% |
| Tooth Extraction |
4.1% |
| Vision Blurred |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Insomnia |
3.7% |
| Anaemia |
3.2% |
| Oedema Peripheral |
3.2% |
| Off Label Use |
3.2% |
| Renal Failure |
3.2% |
| Somnolence |
3.2% |
|
| Interacting |
| Coronary Artery Disease |
29.5% |
| Coronary Arterial Stent Insertion |
19.7% |
| Depression |
11.5% |
| Back Pain |
9.8% |
| Chronic Myeloid Leukaemia |
6.6% |
| Benign Prostatic Hyperplasia |
3.3% |
| Erectile Dysfunction |
3.3% |
| Multiple Sclerosis |
3.3% |
| Muscle Spasms |
3.3% |
| Product Used For Unknown Indication |
3.3% |
| Gastrointestinal Motility Disorder |
1.6% |
| Post Coital Contraception |
1.6% |
| Renal Transplant |
1.6% |
| Smoking Cessation Therapy |
1.6% |
|
| Acute Coronary Syndrome |
18.2% |
| Suicide Attempt |
15.2% |
| Anaphylactic Reaction |
12.1% |
| Thrombosis In Device |
9.1% |
| Shock |
6.1% |
| Alcohol Use |
3.0% |
| Depressed Mood |
3.0% |
| Disease Recurrence |
3.0% |
| Drug Interaction |
3.0% |
| Faeces Discoloured |
3.0% |
| Immunosuppressant Drug Level Increased |
3.0% |
| Malaise |
3.0% |
| Nasopharyngitis |
3.0% |
| Nausea |
3.0% |
| Pregnancy After Post Coital Contraception |
3.0% |
| Somnolence |
3.0% |
| Therapeutic Response Unexpected |
3.0% |
| Toxicity To Various Agents |
3.0% |
|
